Aquestive Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Aquestive Therapeutics Inc
TickerAQST
CIK #0001398733
CUSIP03843E104
SectorLife Sciences - Pharmaceutical Preparations
Address30 Technology Drive, Warren, NJ 07059
Source [EDGAR]
CIK Filing 2011 - 2024
[0001398733] 10-K
[0001398733] 10-Q
[0001398733] 3
[0001398733] 4
[0001398733] 8-K
[0001398733] D
[0001398733] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Madryn Asset Management LP Aquestive Therapeutics Inc [2019-09-09] 5.5
Perceptive Advisors LLC Aquestive Therapeutics Inc [2019-02-14] 8.5
Bratton Douglas K Aquestive Therapeutics Inc [2019-02-13] 16.2
Form 3/4/5 Filer 2011 - 2024
Aquestive Therapeutics, Inc.
Schobel Alexander Mark
Braender Lori J
Barber Daniel
Boyd Peter E.
Marshall Ken W.
Jung Cassie
Wargacki Stephen
Toth A Ernest Jr
Truitt Kenneth
Morris Timothy E
Krop Julie
Cochran John
Brown Gregory B
Taglietti Marco
Costa Santo J
Kendall Keith J
Wood Theresa
Lurker Nancy
Scibetta James S
Bratton Douglas K
Bratton Capital Inc.
MonoLine RX III, L.P.
MRX Partners, LLC
MonoLine RX, L.P.
MonoSol Rx Genpar, L.P.
MonoLine Partners, L.P.
Bratton Capital Management, L.P.
MonoLine RX II, L.P.
Maxwell John T.
Slatko Gary H
Form 13F Holdings
Firm Period DFND Voting Shares
Bratton Capital Management, L.P. [2023-03-31] SOLE 9,810,958.0 9,810,958.0
Vanguard Group Inc [2023-03-31] SOLE 0.0 1,300,816.0
Vahanian & Associates Financial Planning Inc [2023-03-31] SOLE 0.0 718,908.0
Renaissance Technologies LLC [2023-03-31] SOLE 380,294.0 518,800.0
Bracebridge Capital LLC [2023-03-31] SOLE 428,571.0 428,571.0
Geode Capital Management LLC [2023-03-31] DFND 387,575.0 387,575.0
BlackRock Inc. [2023-03-31] SOLE 359,031.0 359,658.0
Millennium Management LLC [2023-03-31] SOLE 302,848.0 302,848.0
Latash Investments LLC [2023-03-31] SOLE 243,134.0 243,134.0
Bridgeway Capital Management LLC [2023-03-31] SOLE 142,956.0 142,956.0
Hightower Advisors LLC [2023-03-31] SOLE 130,305.0 130,305.0
Susquehanna International Group LLP [2023-03-31] DFND 116,272.0 116,272.0
State Street Corp [2023-03-31] DFND 96,037.0 96,037.0
Kestra Advisory Services LLC [2023-03-31] SOLE 0.0 86,350.0
HBK Sorce Advisory LLC [2023-03-31] SOLE 0.0 84,696.0
Northern Trust Corp [2023-03-31] DFND 0.0 59,828.0
Financial Advocates Investment Management [2023-03-31] SOLE 0.0 25,000.0
Jane Street Group LLC [2023-03-31] DFND 23,430.0 23,430.0
Two Sigma Advisers LP [2023-03-31] SOLE 23,100.0 23,100.0
Citadel Advisors LLC [2023-03-31] DFND 17,900.0 17,900.0
Squarepoint Ops LLC [2023-03-31] DFND 0.0 15,542.0
Bank of New York Mellon Corp [2023-03-31] DFND 14,853.0 14,853.0
Virtu Financial LLC [2023-03-31] DFND 12,884.0 12,884.0
DB Root & Company LLC [2023-03-31] SOLE 0.0 12,500.0
Wells Fargo & Company/MN [2023-03-31] DFND 281.0 11,381.0
Vanguard Group Inc [2023-03-31] DFND 0.0 9,770.0
Tower Research Capital LLC (TRC) [2023-03-31] DFND 9,211.0 9,211.0
Morgan Stanley [2023-03-31] DFND 3,070.0 4,670.0
UBS Group AG [2023-03-31] SOLE 3,744.0 3,744.0
Advisor Group Holdings Inc [2023-03-31] DFND 0.0 2,000.0
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com